Histopathology business improvement strategy

27 May 2011
Share this page Email this page to a friend Share this page via Twitter Share this page via Facebook Share this page via LinkedIn

Histopathology services play a vital part in cancer diagnosis for the majority of tumour streams. Fast, accurate histopathology is crucial in finding cancer early, diagnosing it correctly, and choosing and monitoring the best treatment for each patient.

In New South Wales (NSW) and across Australia, there is a growing shortage of tissue pathologists. This shortage is placing histopathology departments under pressure. In response to concern from the Royal College of Pathologists of Australasia (RCPA) about the shortage of tissue pathologists, the Cancer Institute NSW investigated whether process improvements could be made in order to relieve pressure on histopathology services.

The first step in this project was to engage an external consultant, Amica Consulting Pty Ltd, to conduct a pilot project at a public metropolitan histopathology department.

This pilot project identified opportunities to reduce turnaround times - the time taken between the collection of a specimen and reporting of results - even though core processes were consistent with best practice.

Building on the outcomes of the pilot, the consultants were then engaged to undertake a validation project, with three components:

  • Diagnostic analysis: repeating the pilot at a regional public histopathology laboratory and to develop processes and methods applicable to all laboratories;
  • Process improvement: implementing the program of improvements at the public metropolitan histopathology laboratory that had been identified during the pilot; and
  • Management operating system: developing a management operating system for potential deployment to other laboratories across NSW.

During the project, quantitative data was collected and analysed to establish a baseline performance from both sites. Staff members at each facility were also actively involved in mapping laboratory processes and identifying opportunities for improvement.

In the validation phase, suggested solutions were tested and the management operating system was implemented and changes in performance were monitored.

Key Findings

The key findings of the pilot project were:

  • A strong case for change: Even though core processes were consistent with best practice and turnaround times matched those of similar Australian public laboratories, there are still opportunities to reduce turnaround times;

The key improvement opportunities were:

  • Reducing the proportion of cases missing cut‐off times for the next process step
  • Accelerating the progress of medium‐sized samples

There were few mechanisms to actively manage turnaround, meaning that the scope to manage the progress of a case through the laboratory was limited.

The key findings and outcomes of the validation project were:

  • Similar opportunities identified: The diagnostic analysis at the regional public laboratory (where core processes were again consistent with best practice) identified similar opportunities to the metropolitan facility to reduce turnaround times by streamlining process steps for cases.
  • Streamlining workflow: The process improvement program at the public metropolitan laboratory streamlined workflow by minimising interruptions, improving use of space, rationalising code structure and reducing opportunities for error.
  • New guidelines trialed: The process improvement program established agreed turnaround time guidelines for all categories of histopathology samples and implemented a number of changes that will enable immediate gains to be made.
  • Better systems management: The development of a management operating system enabled the flow of cases through the laboratory to be better monitored and provided generic formats for the use of KPIs.

Applicability of findings to other pathology services

Pathology services in Australia are provided by both the public and private sectors. Public laboratories are based in public hospitals. Private laboratories are predominantly community based, carrying out tests at the request of GPs, private hospitals, contracted arrangements with some public hospitals and community-based specialists.

Whether privately or publicly owned, most histopathology services are located in large centralised laboratories in capital cities. These laboratories are commonly associated with a network of smaller regional laboratories, often located within hospitals (public and private) or satellite laboratories.

The project methodology and generic solutions developed during this project are likely to be applicable in similar public laboratories statewide.

However, the following challenges will influence future rollout initiatives beyond the project sites:

  • Centralised reporting: The network structure of pathology services in NSW limits the scope for centralised reporting. Each pathology service tends to use methods that best suit them locally.
  • Consistent information: Partial privatisation of pathology services in NSW has resulted in the lack of uniformity of information systems.
  • Consistent data: The lack of common procurement systems makes it difficult to standardise data, information and operating systems.
  • Customer requirements: Pathology services are also driven by customer requirements, resulting in a diverse reporting environment.

This report describes the findings and outcomes of the pilot and validation projects.

Top of page